Covestor’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Covestor's UTHR Position: Q3 2026 in Review
Covestor increased its United Therapeutics (UTHR) stake by 16% in Q3 2026, buying an estimated $2.07K and bringing the position to 29 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #1215.
Covestor first reported a position in UTHR in Q4 2021 and has held it in 20 quarters since. The position peaked at $259K in Q2 2023. 477 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Covestor held 29 shares of United Therapeutics worth $16K as of Q3 2026.
- Covestor bought 4 United Therapeutics shares in Q3 2026, an estimated $2.07K.
- United Therapeutics made up 0.01% of Covestor's portfolio in Q3 2026, its #1215 holding.
- Covestor first reported a position in United Therapeutics in Q4 2021 and has held it in 20 quarters since.
- Covestor's United Therapeutics position peaked at $259K in Q2 2023.
- 477 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.